Image: The Modus Vis the new cornerstone of the Synaptive BrightMatter platform (Photo courtesy of Synaptive Medical).
A new robotic digital microscope provides superior visualization of the anatomy to meet the complex needs of cutting-edge surgery.
The Synaptive Medical (Synaptive; Toronto; Canada) Modus V is a next generation robotic digital microscope that provides powerful optics that are fully integrated with a robotic surgical arm. The integration provides enhanced hands-free tracking of surgical instruments, with auto-focus and programmable motions that give surgeons more control without disrupting workflow. Increased arm flexibility covers a larger volume of space, permitting more versatile positioning, ergonomic alignments, and greater versatility in the operating room.
The Modus V is part of the Synaptive BrightMatter product suite, which combines the BrightMatter Guide trajectory-centric navigation system to allow surgeons to visualize the brain's internal networks; BrightMatter Vision optics; and BrightMatter Drive robotic arm technologies. The result is an operating room solution that transforms surgical planning, patient data collection, and intraoperative vision from disjointed analog methods to a fully integrated platform with navigation, robotic automation, digital microscopy and data analytics.
“Modus V is an integral part of our overall BrightMatter surgical solution. Conceptualized for the digital era as a fully integrated set of devices, our solution collects and delivers data, be it imaging, tractography or other patient information, when and where it’s most needed to drive surgical decision making,” said Peter Wehrly, CEO of Synaptive. “It’s part of our ongoing commitment to give surgeons the most advanced tools with which to treat their patients.”
“Collaboration is hardwired into Synaptive’s culture. Modus V’s improvements are grounded in the collaboration and extensive feedback from neurosurgeons in our customer community on both Modus V prototypes and BrightMatter Drive,” said Cameron Piron, president and chief strategy officer of Synaptive. “We’re grateful for their support, and look forward to deeper commentary from the surgical community as Modus V enters the market.”